Stay updated on Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial page
- Check2 days agoChange DetectedThe study page now indicates that results have been submitted, replacing the previous 'No Results Posted' status and signaling that results are in the submission/verification process for this trial.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous Revision: v3.6.2. This indicates a minor maintenance update rather than any changes to the study data.SummaryDifference0.0%

- Check23 days agoChange DetectedRevision: v3.6.2 replaces the previous v3.6.0 on the page, reflecting a newer site version. This is a technical update and does not alter the study content or user-facing information.SummaryDifference0.0%

- Check37 days agoChange DetectedThe page now shows a recruitment-status update, indicating enrollment is closed, and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with an Intervention/Treatment labeling change, while removing the old 'Intervention / Treatment' label and the prior 'Revision: v3.5.5' note.SummaryDifference0.4%

- Check45 days agoChange DetectedThe page now lists Revision: v3.5.5, replacing the previous Revision: v3.5.4. This reflects a page version metadata update.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page now displays Revision: v3.5.4, indicating a newer document revision. This reflects a metadata update to the page rather than a change to the study data.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial page.